26 results for «1533»

Filter By

26 results

STEMI Vignettes - The global classroom

18 May 2023 – From EuroPCR 2023

Through these cases, explore global STEMI management and understand various geographic challenges and complication management approaches.

STEMI Vignettes - The global classroom

TAVI with a new generation of valve and difficult arterial access - LIVE case

07 Dec 2023 – From GulfPCR-GIM 2023

An 84-year-old woman with type 2 diabetes, anaemia (Hgb: 9 g/dl), morbid obesity and limited mobility, and mild LV function impairment (50%), presented an acute heart failure on severe aortic valve stenosis.
The operators decided to implant an Evolut FX by femoral access with secondary access in...

Contemporary TAVI in 2023

Emerging indications for TAVI

18 May 2023 – From EuroPCR 2023

Consult this session if you want to learn about emergent indications of transcatheter treatment of aortic valve disease, to appreciate current gaps in the evidence base and hear about upcoming clinical trials, and to highlight new technologies that will address these treatment gaps.

Emerging indications for TAVI

Challenging TAVI procedures

18 May 2023 – From EuroPCR 2023

Discover a selection of challenging TAVI procedures in this session: explore the management of complex polidistrectual vasculopathy in patients with severe aortic stenosis, encounter a challenging case of TAVI involving balloon rupture during BAV, delve into the intricacies of performing TAVR in patients with coarctation of...

Challenging TAVI procedures

Equity in STEMI management: bridging gaps in STEMI care for women

15 May 2024 – From EuroPCR 2024

This joint session with the Stent - Save a Life! initiative focuses on the unique challenges in STEMI diagnosis and management for women. It explores different pathological processes resulting in STEMI and STEMI mimics in women, and discusses optimal management techniques. The session features perspectives from...

Equity in STEMI management: bridging gaps in STEMI care for women

Future directions of drug-coated balloon angioplasty

06 Feb 2025

Fernando Alfonso and Javier Cuesta discuss the growing role of drug-coated balloons as an alternative to stents in percutaneous coronary interventions. Highlighting advantages like reduced in-stent restenosis, they emphasize the need for robust clinical studies to refine DCB use.

Dr. F. Alfonso

Author

Fernando Alfonso
Javier Cuesta

Author

Javier Cuesta
Future directions of drug-coated balloon angioplasty
Didn’t find what you were looking for?